Aclaris Therapeutics (ACRS) Receivables - Other (2019 - 2021)
Aclaris Therapeutics' (ACRS) quarterly Receivables - Other came in at $24000.0 in Q4 2021, down 92.0% year-on-year from $300000.0 in Q4 2020, and little changed quarter-over-quarter from $24000.0 in Q3 2021.
Aclaris Therapeutics (ACRS) Receivables - Other (2019 - 2021) Analysis & Trends
Aclaris Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $24000.0 for Q4 2021.
- On a quarterly basis, Receivables - Other fell 92.0% year-over-year to $24000.0 in Q4 2021; TTM through Dec 2021 was $24000.0, a 92.0% decrease from a year earlier, with the FY2021 full-year figure at $24000.0, down 92.0% from the prior year.
- Receivables - Other steadied at $24000.0 in Q4 2021 per ACRS's latest filing, from $24000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $300000.0 in Q2 2020 and bottomed at $20000.0 in Q1 2021.
- The 3-year median for Receivables - Other is $100000.0 (2019), against an average of $143555.6.
- Across the five-year window, Receivables - Other jumped 200.0% in 2020 and tumbled 92.0% in 2021, its largest moves.
- Year by year, Receivables - Other stood at $100000.0 in 2019, then soared by 200.0% to $300000.0 in 2020, then tumbled by 92.0% to $24000.0 in 2021.
- Per Business Quant, the three latest ACRS Receivables - Other figures stand at $24000.0 (Q4 2021), $24000.0 (Q3 2021), and $24000.0 (Q2 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aclaris Therapeutics | 705.88 Mn | 705.88 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 24,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 24,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Mar 31, 2021 | 20,000.00 |
| Dec 31, 2020 | 300,000.00 |
| Dec 31, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Jun 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Mar 31, 2020 | 200,000.00 |
| Sep 30, 2019 | 100,000.00 |
| Sep 30, 2019 | 100,000.00 |